期刊文献+

STUDY ON SOLIDIFIED TUMOR VACCINE PREPARED FROM AUTOGENOUS CANCEROUS TISSUE

STUDY ON SOLIDIFIED TUMOR VACCINE PREPARED FROM AUTOGENOUS CANCEROUS TISSUE
下载PDF
导出
摘要 In order to evaluate the immune effects of hyperthermically solidified tumor vaccine (STV) prepared from autogenous caucerous tissue,experimental study on mice and clinical application were performed. It was found that Balb/c mice immunized with STV could resist the attack of 3×108 cells of H22 liver cancer with an survival rate of 93.3% (28/30) and the 2-year survival rate of the patients treated with STV prepared from autogenous cancerous tissue was 60%(18/30)as compared with 13.5% (5/37)of the control(P<0.01). In order to evaluate the immune effects of hyperthermically solidified tumor vaccine (STV) prepared from autogenous caucerous tissue,experimental study on mice and clinical application were performed. It was found that Balb/c mice immunized with STV could resist the attack of 3×108 cells of H22 liver cancer with an survival rate of 93.3% (28/30) and the 2-year survival rate of the patients treated with STV prepared from autogenous cancerous tissue was 60%(18/30)as compared with 13.5% (5/37)of the control(P<0.01).
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1995年第3期225-229,共5页 中国癌症研究(英文版)
关键词 Liver cancer Solidified tumor vaccine Immune function. Liver cancer,Solidified tumor vaccine,Immune function.
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部